This week the central bank hiked interest rates by three quarters of a percentage point, the biggest increase since 1994, and signaled it could do it again next month.
The move was aimed to try to curb inflation, but could it have an impact on the biotech industry as well? Les Funtleyder is a health care portfolio manager with E Squared Capital Management and chief investment officer of Technic Health, which makes investments in private health care companies. He joined the hosts of “The Readout LOUD” this week to discuss.
Create a display name to comment
This name will appear with your comment
